To note, hNSCs still retain TLR4 expression in vivo, after transplantation into ALS rats and immunocompromised mice, suggesting TLR4 as a novel target for future therapeutic approaches. This evidence concerns the gene TLR4 and amyotrophic lateral sclerosis.